June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Walgreens, Rite Aid Ditch Long-Suffering Drugstore Merger

Published 06/29/2017, 01:28 AM
Updated 07/09/2023, 06:31 AM
WBA
-
FREDQ
-
US90274J5618=UBSS
-

On Thursday, Walgreens Boots Alliance (NASDAQ:WBA) announced that it has abandoned efforts to merge with fellow drugstore chain Rite Aid (NYSE:RAD) . Instead, Walgreens will purchase almost half if its rivals stores after the deal passes U.S. regulatory scrutiny from the Federal Trade Commission.

In premarket trading, shares of Walgreens were up about 3.7%, though it has settled a bit, and is currently down 0.60% in late-morning trading. Rite Aid shares were down over 4% in premarket trading, and have now plunged over 26% in light of the news.

Under the terms of the new deal, Walgreens will acquire 2,186 Rite Aid stores and related assets for $5.175 billion. Rite Aid will remain a “multi-regional” drugstore chain, and the store locations being acquired are primarily in the Northeast, Mid-Atlantic, and Southeastern regions of the U.S.

“It will allow us to expand and optimize our retail pharmacy network in key markets in the U.S., including the Northeast, and provide customers and patients with greater access to convenient, affordable care," Walgreens CEO Stefano Pessina said. "We believe this new transaction addresses competitive concerns previously raised with respect to the prior transaction."

For Walgreens, the new transaction will be significantly less expensive. The original deal between the drugstore giant and its smaller competitor came in at about $9.4 billion, though the price range was lowered between $6.8 billion to $7.4 billion in January. The new deal stays “true to our original strategic aim," Pessina said. "Overall I view this deal as being more attractive than the transaction it replaces."

For Rite Aid, the company said it will use the proceeds to pay down debt, and the bonds gained on that news. Bloomberg notes that the company’s “6.75 percent unsecured notes due in 2021 rose as much as 4 cents on the dollar to 102.875,” while the 7.7 percent notes due in 2027 were trading as high as 102.75 Thursday morning in New York.”

"While we believe that pursuing the merger with WBA was the right thing to do for our investors and customers, this new agreement provides a clear path forward and positions Rite Aid as a strong, independent, multi-regional drugstore chain and pharmacy benefits manager with a compelling footprint in key markets," Rite Aid CEO John Standley said in a statement.

This new deal also means that pharmacy chain Fred’s Inc. (NASDAQ:FRED) will no longer be a buyer of Rite Aid stores. Last December, the company announced it would purchase 865 stores for $950 million in cash. Shares of Fred’s are down about 19% in late-morning trading. The pharmacy operates stores in 16 Southeastern states

Walgreens said it will begin taking over the Rite Aid stores over a period of about six months, and intends to covert the stores to the Walgreens name brand over time.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2%, respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>



Fred's, Inc. (FRED): Free Stock Analysis Report

Rite Aid Corporation (RAD): Free Stock Analysis Report

Walgreens Boots Alliance, Inc. (WBA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.